Aged macular degeneration: current therapeutics for management and promising new drug candidates
Author:
Funder
National Health and Medical Research Council
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference68 articles.
1. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis;Wong;Lancet Global Health,2014
2. Age-related Macular Degeneration Diagnosis and Treatment;Ho,2011
3. Clinical classification of age-related macular degeneration;Ferris;Ophthalmology,2013
4. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature;Falavarjani;Eye,2013
5. Individual recurrence intervals after anti-VEGF therapy for age-related macular degeneration;Hörster;Graefes Arch. Clin. Exp. Ophthalmol.,2011
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhanced Therapeutic Intervention of Curcumin Loaded in Exosomes Derived from Milk in Alleviating Retinal Pigment Epithelial Cells Damage;2024
2. Role of flavonoids in age-related macular degeneration;Biomedicine & Pharmacotherapy;2023-03
3. Chitooligosaccharides Derivatives Protect ARPE-19 Cells against Acrolein-Induced Oxidative Injury;Marine Drugs;2023-02-22
4. Nanomedicine: Principles, properties, and regulatory issues;Smart Polymeric Nano-Constructs in Drug Delivery;2023
5. Highly Retina-Permeating and Long-Acting Resveratrol/Metformin Nanotherapeutics for Enhanced Treatment of Macular Degeneration;ACS Nano;2022-12-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3